PARP inhibition in breast and ovarian patient-derived tumor xenografts (PDX) harboring germline BRCA1/2 mutations unveils mechanisms of primary and acquired resistance that restore homologous recombination (HR) Meeting Abstract
| Authors: | Cruz, C.; Bustos, L.; Gris, A.; Palafox, M.; Castroviejo, M.; Llop, A.; Morancho, B.; Diez, O.; Gutiérrez, S.; Caratú, G.; Prudkin, L.; Bruna, A.; Caldas, C.; O'Connor, M. J.; Rubio, I. T.; Arribas, J.; Baselga, J.; Cortes, J.; Serra, V.; Balmaña, J. |
| Abstract Title: | PARP inhibition in breast and ovarian patient-derived tumor xenografts (PDX) harboring germline BRCA1/2 mutations unveils mechanisms of primary and acquired resistance that restore homologous recombination (HR) |
| Meeting Title: | 38th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) |
| Journal Title: | Cancer Research |
| Volume: | 76 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2015 Dec 8-12 |
| Meeting Location: | San Antonio, TX |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2016-02-15 |
| Language: | English |
| ACCESSION: | WOS:000375622403491 |
| PROVIDER: | wos |
| DOI: | 10.1158/1538-7445.SABCS15-P4-07-05 |
| Notes: | Meeting Abstract: P4-07-05 -- Source: Wos |
